Advanced pulmonary sarcoidosisPulmonary fibrosisStage 4 sarcoidosisLung transplantationMortalityMycetomaSarcoidosis is rarely an "end-stage" disease鈥攁 concept that implies futility of further treatment. Instead, we suggest the use of the term advanced pulmonary sarcoidosis which encompasses the ideas that ...
Stage four sarcoidosis is a little bit different than the other three. Stage four indicates scarring in the lungs- pulmonary fibrosis- which is irreversible. Because of this, stage four is the most severe presentation of sarcoidosis. This also contributes to the misconception that the stages of ...
Sarcoidosis is rarely an "end-stage" disease—a concept that implies futility of further treatment. Instead, we suggest the use of the term advanced pulmonary sarcoidosis which encompasses the ideas that the disease has progressed to the point that there is substantial morbidity, there is relatively...
1. 末期 4.疾病末期(endstage):在此阶段,个案无法认得家人,照镜子亦无法认得自己。tw.myblog.yahoo.com|基于2个网页 例句 释义: 全部,末期 更多例句筛选 1. Four-year follow-up of a patient with endstage pulmonary sarcoidosis treated by single lung transplantation 单肺移植术后四年随访 www.ilib.cn隐...
5 Pulmonary hypertension with unclear or multifactorial mechanisms Myeloproliferative disorders, sarcoidosis, glycogen-storage disease, chronic kidney disease, and miscellaneous disorders Unexplained PH in CKD/ESRD Abbreviations: AKI, acute kidney injury; AV, arteriovenous; CKD, chronic kidney disease; COPD,...
Pulmonary sarcoidosis is frequently classified ac-cording to appearances on chest radiography. A radiographic system, developed more than five decades ago, defines the following stages: stage 0 (normal appearances); stage I (bilateral hilar lympha 选择语言:从 到 翻译结果1翻译结果2 翻译结果3翻译...
One fatal adverse reaction of pulmonary hemorrhage occurred. Permanent discontinuation of KEYTRUDA due to an adverse reaction occurred in 12% of patients who received KEYTRUDA as a single agent, given as adjuvant...
Serious adverse reactions occurred in 28% of patients; those ≥2% were pneumonia (3%), cardiac ischemia (2%), colitis (2%), pulmonary embolism (2%), sepsis (2%), and urinary tract infection (2%). The most common adverse reactions (≥20%) w...
Abstract The societal burden of heart failure is well recognized; there are currently estimated to be over six million adults with HF in the United States and over 23 million worldwide. Both age-adjusted death rates and hospitalizations for heart failure have been increasing, and despite advances...
Volume overload or pulmonary edema should be treated with loop diuretics or ultrafiltration. For uremic manifestations, long-term renal replacement therapy (hemodialysis, peritoneal dialysis, or kidney transplantation) is needed. Anemia is treated with an erythropoiesis-stimulating agent (ESA) such as er...